Which phase of clinical trials primarily aims to evaluate the efficacy and optimal dose of a new treatment in patients with the target disease?

Question

BlackTom AI · Accepted Answer

Phase II trials focus on evaluating efficacy and determining the optimal dose in patients who have the target disease, so the correct answer is a. Phase II clinical trial.

1) Relevant knowledge points and concepts
- Clinical trials progress through phases I–IV with distinct goals.
- Phase I: primary aim is safety, tolerability, and initial pharmacokinetics/pharmacodynamics (usually in a small number of healthy volunteers or sometimes patients).
- Phase II: tests preliminary efficacy (proof‑of‑concept) and explores dose–response to establish an optimal dosing regimen in patients with the disease.
- Phase III: large confirmatory trials to demonstrate efficacy and safety versus standard therapy or placebo to support regulatory approval.
- Phase IV: post‑marketing surveillance to monitor long‑term safety and effectiveness.
- Bioavailability trials assess absorption/PK characteristics (often for formulation or equivalence studies), not clinical efficacy.

2) Step‑by‑step reasoning
- The question asks which phase “primarily aims to evaluate the efficacy and optimal dose” in patients with the target disease.
- Phase I concentrates on safety and dosing ranges but usually in healthy volunteers and is not primarily designed to determine efficacy in diseased patients.
- Phase II enrolls patients with the disease to measure therapeutic effects and to perform dose‑finding (dose‑ranging) studies—this matches both “efficacy” and “optimal dose.”
- Phase III confirms efficacy and safety on a larger scale but is not the primary setting for initial dose optimization.
- Phase IV and bioavailability trials do not match the described objective.

3) Calculations / intermediate steps
- No numerical calculations are required; reasoning is based on trial purpose and design.

4) Why the correct answer is correct
- Phase II is the conventional phase where investigators test whether the drug has the intended therapeutic effect in patients and identify the dose that balances efficacy and tolerability.

5) Why the other options are incorrect (briefly)
- b. Phase IV: post‑marketing surveillance, not initial efficacy/dose finding.
- c. Phase I: safety and PK, small numbers, not focused on efficacy in patients.
- d. Phase III: large confirmatory trials after dose and preliminary efficacy are established.
- e. Bioavailability trial: measures drug absorption/PK, not clinical efficacy or dose optimization.

6) Conclusion
- Therefore, the correct answer is a. Phase II clinical trial, which matches the provided answer.

Which phase of clinical trials primarily aims to evaluate the efficacy and optimal dose of a new treatment in patients with the target disease?单项选择题

类似问题

Multiple Choice: In which of the following cases would a randomized controlled trial be required to show efficacy of a probiotic supplement?

Why is Australia an attractive location for conducting Phase I clinical trials?

Which member of the clinical trial team is responsible for the overall conduct of the trial at a study site?

How long do Phase III clinical trials typically run?

Which clinical trial design involves assigning participants to different treatment groups, where each group receives only one treatment throughout the study?

Adverse events are difficulties that participants reported about the interventions provided in the study. These are listed in the Results section. Based on what was reported in final paragraph of the results section, select from the list below which adverse event were reported by participants.

What is the typical probability of success for a drug in Phase 1 trials ?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单